- Investing.com
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. Medios AG was founded in 2016 and is headquartered in Berlin, Germany.
Metrics to compare | ILM1k | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipILM1kPeersSector | |
---|---|---|---|---|
P/E Ratio | 25.8x | −1.1x | −0.7x | |
PEG Ratio | −0.78 | 0.02 | 0.00 | |
Price/Book | 0.7x | 0.9x | 2.6x | |
Price / LTM Sales | 0.2x | 0.4x | 3.2x | |
Upside (Analyst Target) | 170.5% | 36.3% | 46.4% | |
Fair Value Upside | Unlock | 21.5% | 6.9% | Unlock |